Maria Echavez-Arroyo
Internal Medicine · Tampa, FLNPI 1952506925
Payments from drug & device makers
Across 122 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$553
- AstraZeneca$241
- Novo Nordisk$214
- Biohaven Pharmaceutical Holding Company Ltd.$173
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$165
- Lilly USA, LLC$110
- plus $750 from 22 others
What the payments were for
- Food & beverage$2,207100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $553 |
| AstraZeneca | 14 | $241 |
| Novo Nordisk | 15 | $214 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $173 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $165 |
| Lilly USA, LLC | 7 | $110 |
| Boehringer Ingelheim | 5 | $92 |
| Amgen | 5 | $75 |
| Bayer | 4 | $75 |
| Novartis | 4 | $60 |
| Abbott | 3 | $58 |
| Amarin Pharma, Inc. | 2 | $39 |
| Exact Sciences | 2 | $36 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Sanofi Pasteur Inc. | 2 | $31 |
| Johnson & Johnson | 2 | $30 |
| Astellas Pharma US Inc | 1 | $23 |
| Dynavax Technologies Corporation | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Vistapharm, Inc. | 1 | $15 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$121
How this compares
$2,207 in reported general payments places this provider in the 80th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 24 | $548 |
| Bupropion XlBupropion Hcl | 18 | $276 |
| Pantoprazole Sodium | 19 | $251 |
| Atorvastatin Calcium | 23 | $238 |
| Lisinopril | 15 | $176 |
| Levothyroxine Sodium | 13 | $112 |
| Losartan Potassium | 11 | $104 |
| Amlodipine Besylate | 11 | $71 |
| Simvastatin | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Tampa
- Jhanelle GrayTampa$20.8M
- Sady AlpizarTampa$13.5M
- Karon LociceroTampa$6.6M
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.